Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
D000328:Adult; D000818:Animals; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D002460:Cell Line; D002642:Chick Embryo; D000882:Haplorhini; D006382:Hemadsorption; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007110:Immunity, Active; D007252:Influenza Vaccines / Q000592:standards*; D007251:Influenza, Human / Q000097:blood / Q000276:immunology / Q000517:prevention & control*; D007668:Kidney; D008168:Lung; D008297:Male; D008722:Methods; D009093:Mucus / Q000276:immunology; D009439:Neuraminidase / Q000378:metabolism; D009666:Nose / Q000382:microbiology; D009975:Orthomyxoviridae / Q000201:enzymology / Q000302:isolation & purification; D011995:Recombination, Genetic; D014611:Vaccination; D014776:Virus Cultivation
D007252:Influenza Vaccines; D009439:Neuraminidase